← Leaderboards
Maelene L Wong
Vivita Technologies, Inc.
$2,216,736
Attributed
$2,216,736
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $751.3K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,216,736 · 3
By mechanism
R44$1,495,505 · 1
R43$721,231 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Fostering”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Klaus Romero · Critical Path Institute$58,665,332
- Prasant Mohapatra · University Of California At Davis$41,945,816
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Oliver Brand · Emory University$18,504,645
- Abraham Aizer Brody · New York University School Of Medicine$16,015,961
Research focus
FosteringFutureExtracellular MatrixFamily SuidaeCostFundingCattleExcisionCollaborationsFailureCardiac Surgery ProceduresAntigensAdaptive Immune ResponseCalcificationAnimalsBiomaterials ResearchCardiovascular SystemDesignBiocompatible MaterialsChronicBioprosthesis DeviceClinical PracticeAmerican Heart AssociationGlutaral
Grant awards (4)
Unfixed, xenogeneic extracellular matrix for crimp damage-resistant and regenerative transcatheter heart valve prostheses$496,255
R43 · FY2025 · HL · contact PI
Immune-compatible, unfixed, xenogeneic extracellular matrix for heart valve prostheses$744,229
R44 · FY2023 · HL · contact PI
Immune-compatible, unfixed, xenogeneic extracellular matrix for heart valve prostheses$751,276
R44 · FY2022 · HL · contact PI
Novel xenogeneic extracellular matrix biomaterial for cardiovascular prostheses$224,976
R43 · FY2017 · HL · contact PI